Displaying items by tag: oneal comprehensive cancer center
This funding supports local breast cancer research projects across Alabama.
The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors say.
The infusion therapy can help shrink tumors that are otherwise inoperable.
The 10-week trial will include meals provided by study investigators.
Young cancer survivors are at higher risk of developing subsequent HPV-related cancers than the general population, but less likely to receive the HPV vaccine. Findings from the first clinical trial of its kind support making HPV vaccination a routine part of oncologic care for all young cancer survivors, researchers say.
- release
- office of the president
- office of the provost for student and faculty success
- uab strategic plan
- school of medicine
- college of arts and sciences
- oneal comprehensive cancer center
- school of public health
- department of medicine
- division of infectious diseases
- department of surgery
- department of biochemistry and molecular genetics
- department of clinical and diagnostic sciences
- department of microbiology
- department of pharmacology and toxicology
- division of cardiovascular disease
- division of endocrinology diabetes and metabolism
- department of psychology
- department of environmental health sciences
Join UAB’s Dr. Mona Fouad to hear a discussion on implicit and explicit bias in the field of science and medicine.
The NIH grant creates Multiple Chronic Disease Centers around the nation to target chronic disease in minority populations.
Blood and marrow transplantation strategies have changed significantly over the past four decades; but recipients still experience excess mortality that translates into 8.7 years of life lost, according to researchers in UAB’s Institute for Cancer Outcomes and Survivorship.
This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.
